P197: Use of 6-thioguanine nucleotide concentration test in the management of patients with Crohn’s disease in KoreaECCO '16 Amsterdam
2016
P198: Faecal calprotectin level correlates well with balloon-assisted endoscopy and computed tomography enterography findings in small bowel Crohn’s diseaseECCO '16 Amsterdam
2016
P199: Predictive factors of surgery and bowel damage during the course of Crohn’s disease: A population-based studyECCO '16 Amsterdam
2016
P201: Disability and health-related quality of life in patients with moderate-severe ulcerative colitis: impact of restorative proctocolectomy versus medical treatment with anti-tumour necrosis factor agentsECCO '16 Amsterdam
2016
P202: Meta-analysis: accuracy of interferon-γ release assays in differentiating intestinal tuberculosis from Crohn’s disease in AsiaECCO '16 Amsterdam
2016
P204: Ultrasound elastography–derived shear wave velocity helps distinguish acutely inflamed from fibrotic bowel in patients with Crohn’s disease receiving surgeryECCO '16 Amsterdam
2016
P205: Prevalence of anaemia in a nationwide cohort of elderly onset ulcerative colitis patientsECCO '16 Amsterdam
2016
P206: Combined positron emission tomography and magnetic resonance imaging in the diagnostics of inflammatory bowel disease: a preliminary reportECCO '16 Amsterdam
2016
P207: Disease activity is associated with indicators of impaired nutritional status in inflammatory bowel disease outpatientsECCO '16 Amsterdam
2016
P208: Prevalence of chronic peri-pouch sepsis in patients treated as primary idiopathic pouchitisECCO '16 Amsterdam
2016
P209: Extraintestinal manifestations are a prognostic factor in patients with inflammatory bowel diseaseECCO '16 Amsterdam
2016
P210: Telemedicine for inflammatory bowel disease patients with MyIBDcoach: description of the myIBDcoach trialECCO '16 Amsterdam
2016
P211: Anti-tumour necrosis factor drugs levels and correlation with short-term clinical remission in Crohn’s disease patients: results from the Predicrohn StudyECCO '16 Amsterdam
2016
P212: Inflammatory bowel disease patients seem to develop non-alcoholic steatohepatitis (NASH) independently from an altered metabolic profile or active bowel diseaseECCO '16 Amsterdam
2016
P213: Predicting outcome of paediatric Crohn’s disease: role of clinical, endoscopic, and imaging findings at the diagnosisECCO '16 Amsterdam
2016